Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin αvβ3 and coxsackie adenovirus receptor

International Journal of Cancer

Volumn 110, Issue 5, 2004, Pages 660-667

  Ambriović Ristov, Andreja ^a   Gabrilovac, Jelka ^a   Čimbora Zovko, Tamara ^a   Osmak, Maja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Adenovirus type 5; Cisplatin resistant cells; Coxsackie adenovirus receptor; Transduction; Transduction efficacy; v 3 integrins

Indexed keywords

ADENOVIRUS VECTOR; CISPLATIN; VITRONECTIN RECEPTOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CORRELATION ANALYSIS; COXSACKIE VIRUS; DISEASE ASSOCIATION; FLOW CYTOMETRY; GENE THERAPY; HUMAN; HUMAN CELL; LARYNX CARCINOMA; MOLECULAR CLONING; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS MUTATION; WILD TYPE;

EID: 2942591942     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.5555/ijc.20176     Document Type: Article

References (48)

1. Russell WC. Update on adenovirus and its vectors. J Gen Virol 2000;81:2573-604.
2. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-3.
3. Li E, Brown SL, Stupack DG, Puente XS, Cheresh DA, Nemerow GR. Integrin αvβ1 is an adenovirus coreceptor. J Virol 2001;75:5405-9.
4. Nemerow GR. Cells receptors involved in adenovirus entry. Virology 2001;274:1-4.
5. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994;127:257-64.
6. 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-19.
7. Asaoka K, Tada M, Sawamura Y, Ikeda J, Abe H. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the coxsackievirus and adenovirus receptor. J. Neurosurg 2000;92:1002-8.
8. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, Belousova N, Curiel DT. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor independent cell entry mechanism. J Virol 1998;72:9706-13.
9. Fuxe J, Liu L, Malin S, Philipson L, Collins VP, Pettersson RF. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer 2003;103:723-9.
10. Hemmi S, Geertsen R, Mezzacasa A, Peter I, Dummer R. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures. Hum Gene Ther 1998;9:2363-73.
11. Li Y, Pong R-C, Bergelson JM, Hall MC, Sagalowsky AI, Tseng C-P, Wang Z, Hsieh J-T. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999;59:325-30.
12. Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer. Cancer Res 1998;58:5738-48.
13. 3. Hum Gene Ther 2001;12:391-399.
14. Pearson AS, Koch PE, Atkinson N, Xiong M, Finberg RW, Roth JA, Fang B. Factors limiting adenovirus-mediated gene transfer into human lung and pancreatic cancer cell lines. Clin Cancer Res 1999;5:4208-13.
15. Turturro F, Seth P, Link CJ. In vitro adenoviral vector p53-mediated transduction and killing correlates with expression of coxsackie-adenovirus receptor and alpha v beta 5 integrin in SUDHL-1 cells derived from anaplastic large-cell lymphoma. Clin Cancer Res 2000;6:185-92.
16. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997;94:3352-6.
17. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 2001;98:15191-6.
18. Okegawa T, Li Y, Pong R-C, Bergelson JM, Zhou J, Hsieh J-T. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000;60:5031-6.
19. Okegawa T, Pong R-C, Li Y, Bergelson JM, Sagalowski AI, Hsieh J-T. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of CAR protein structure. Cancer Res 2001;61:6592-600.
20. Danen EHJ, Sonnenberg A. Integrins in regulation of tissue development and function. J Pathol 2003;200:471-80.
21. Wehrle-Haller B, Imhof B. Integrin-dependent pathologies. J Pathol 2003;200:481-7.
22. Damiano JS. Integrins as novel drug targets for overcoming innate drug resistance, Curr Canc Drug Targets 2002;2:37-43.
23. Osmak M, Beketić-Orešković L, Matulić M, Sorić J. Resistance of human larynx carcinoma cells to cisplatin, gamma irradiation and metotrexate do not involve overexpression of c-myc or c-Ki-ras oncogenes. Mutat Res 1993;303:113-20.
24. Osmak M. Collateral resistance or sensitivity of human larynx carcinoma HEp2 cells resistant to cis-dichlorodiammineplatinum(II) or vincristine sulphate. Neoplasma 1992;39:197-202.
25. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human Ad5. J Gen Virol. 1977;75:133-9.
26. Mickisch G, Fajta S, Keilhauer G, Schlick E, Tschada R, Alken P. Chemosensitivity testing of primary human renal cell carcinoma by tetrazolium based microculture assay (MTT). Urological Res 1990;18:131-6.
27. Ambriović-Ristov A, Mercier S, Eloit M. Shortening adenovirus type 5 fiber shaft decreases the efficiency of postbinding steps in CAR-expressing and nonexpressing cells. Virology 2003;312:425-33.
28. Sambrook J, Fritsch E, Maniatis T. Molecular Cloning, A Laboratory Manual, Book 3. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
29. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
30. Okada N, Tsukada Y, Nakagawa S, Mizuguchi H, Mori K, Saito T, Fujita T, Yamamoto A, Hayakava T, Mayumi T. Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors. Biochem Biophys Res Comm 2001;282:173-9.
31. Duplaa C, Couffinhal T, Dufourcq P, Llanas B, Moreau C, Bonnet J. The integrin very late antigen-4 is expressed in human smooth muscle cell. Circulation Res 1997;80:159-69.
32. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M. Significance of integrin α5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000;6:96-101.
33. Tang DG, Diglio CA, Bazaz R, Honn KV. Transcriptional activation of endothelial cell integrin αv by protein kinase C activator 12(S)-HETE. J Cell Sci 1995;108:2629-44.
34. Hong SS, Bardy M, Monteil M, Gay B, Denesvre C, Tournier J, Martin G, Eloit M, Boulanger P. Immunoreactive domains and integrin-binding motifs in adenovirus penton base capsomer. Viral Immunol 2000;13:353-71.
35. Nista A, Leonetti C, Bernardini G, Mattioni M, Santoni A. Functional role of α4β1 and α5β1 integrin fibronectin receptors expressed on adriamycin-resistant MCF-7 human mammary carcinoma cells. Int J Cancer 1997;72:133-41.
36. Shirakawa T, Sasaki R, Gardner TA, Kao C, Zhang Z-J, Sugimura K, Matsuo M, Kamidono S, Gotoh A. Drug-resistant human bladder-cancer cells are more sensitive to adenovirus-mediated wild-type p53 gene therapy compared to drug-sensitive cells. Int J Cancer 2001;94:282-9.
37. Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, Curiel DT. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res 2003;63:847-53.
38. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 1999;93:1658-67.
39. Sethi T, Rintoul RC, Moore SM, MacKinnon Ac, Salter D, Choo C, Chilvers ER, Dransfield I, Donnely SC, Strieter R, Haslett C. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med 1999;5:662-8.
40. Aoudjit F, Vuori K. Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene 2001;20:4995-5004.
41. Hazlehurst LA, Valkov N, Wisner L, Storey JA, Boulware D, Sullivan DM, Dalton WS. Reduction in drug-induced DNA double strand breaks associated with β1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Blood 2001;98:1897-903.
42. Narita T, Kimura N, Sato M, Matsuura N, Kannagi R. Altered expression of integrins in adriamycin-resistant human breast cancer cells. Anticancer Res 1998;18:257-62.
43. Maubant S, Cruet-Hennequart S, Poulain L, Carreiras F, Sichel F, Luis J, Staedel C, Gauduchon P. Altered adhesion properties and alpha V integrin expression in a cisplatin-resistant human ovarian carcinoma cell line. Int J Cancer 2002;97:186-194.
44. 3-mediated activation of apoptosis. Exp Cell Res 1999;251:33-45.
45. Eliceiri BP, Cheresh DA. The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999;103:1227-30.
46. Uhm JH, Dooley NP, Kyritsis AP, Rao JS, Gladson CL. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin Cancer Res 1999;5:1578-94.
47. Kozlova NI, Morozevich GE, Chubukina AN, Berman AE. Integrin αvβ3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells. Oncogene 2001;20:4710-7.
48. Takayama K, Ueno H, Pei XH, Nakanishi Y, Yatsunami J, Hara N. The levels of integrin alpha v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cell. Gene Ther 1998;5:361-8.